Darrell J. Irvine,Bruce D. Walker,Richard Bradley Jones
申请号：
US14075485
公开号：
US20140170221A1
申请日:
2013.11.08
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention provides compositions and methods for delivering an agent to virally infected tissues and/or cells of a subject by conjugating agent-loaded nanoparticles to virus-specific T cells, such as cytotoxic T lymphocytes. The agent may be a latency-reversing drug (LRD), an antiviral agent and/or an agent that enhances cytotoxic efficacy of T lymphocytes.
